Keane Raymond T 4
4 · ARIAD PHARMACEUTICALS INC · Filed Mar 22, 2013
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Exercise/Conversion
Common Stock
2013-03-20+4,667→ 40,681 total - Sale
Common Stock
2013-03-22$19.46/sh−2,334$45,423→ 38,347 total - Exercise/Conversion
Restricted Stock Units
2013-03-20−4,667→ 0 total→ Common Stock (4,667 underlying)
Footnotes (4)
- [F1]Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
- [F2]Represents shares withheld to satisfy withholding tax requirements.
- [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The restricted stock units vested on March 20, 2013.